Tyra Biosciences (TYRA) Total Current Liabilities (2020 - 2026)

Tyra Biosciences' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $19.3 million for Q1 2026.

• Quarterly Total Current Liabilities rose 35.17% year-over-year to $19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.3 million (up 35.17% YoY) and the FY2025 annual result came in at $18.1 million, up 23.98% from the prior year.
• Total Current Liabilities was $19.3 million for Q1 2026 at Tyra Biosciences, up from $18.1 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $19.3 million in Q1 2026 and bottomed at $3.7 million in Q1 2023.
• A 5-year average of $10.8 million and a median of $10.4 million in 2024 frame the typical range for Total Current Liabilities.
• Peak annual rise in Total Current Liabilities reached 168.95% in 2023, while the deepest fall reached 24.87% in 2023.
• Tyra Biosciences' Total Current Liabilities stood at $5.7 million in 2022, then surged by 168.95% to $15.3 million in 2023, then declined by 4.82% to $14.6 million in 2024, then advanced by 23.98% to $18.1 million in 2025, then advanced by 6.42% to $19.3 million in 2026.
• Business Quant data shows TYRA's Total Current Liabilities at $19.3 million in Q1 2026, $18.1 million in Q4 2025, and $15.9 million in Q3 2025.